Publications by authors named "Marc Heckmann"

Claim this Profile
P
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data.
Nowell Solish, Benjamin Ascher, Rui L Avelar, Vince Bertucci, Isaac Bodokh, Marc Heckmann

Aesthet Surg J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Benjamin Ascher, Berthold Rzany, Philippe Kestemont, Said Hilton, Marc Heckmann

Aesthet Surg J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance".
Benjamin Ascher, Berthold Rzany, Philippe Kestemont, Said Hilton, Marc Heckmann

Aesthet Surg J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.
Benjamin Ascher, Berthold Rzany, Philippe Kestemont, Said Hilton, Marc Heckmann

Aesthet Surg J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Berthold-Josef Rzany, Benjamin Ascher, Rui L Avelar, Jesper Bergdahl, Vince Bertucci, Marc Heckmann

Aesthet Surg J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Benjamin Ascher, Berthold Rzany, Philippe Kestemont, Said Hilton, Marc Heckmann

Aesthet Surg J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aktualisierung der S1-Leitlinie zur Definition und Therapie der primären Hyperhidrose.
Berthold Rzany, Falk G Bechara, Konstantin Feise, Marc Heckmann, Stefan Rapprich

J Dtsch Dermatol Ges· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update of the S1 guidelines on the definition and treatment of primary hyperhidrosis.
Berthold Rzany, Falk G Bechara, Konstantin Feise, Marc Heckmann, Stefan Rapprich

J Dtsch Dermatol Ges· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial.
Benjamin Ascher, Philippe Kestemont, Dominique Boineau, Isaac Bodokh, Annette Stein, Marc Heckmann

Aesthet Surg J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
Michael Schwameis, Thomas Kündig, Gustave Huber, Luzi von Bidder, Lorenz Meinel, Marc Heckmann

Lancet Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of self-esteem and depression symptoms in depressed and nondepressed subjects treated with onabotulinumtoxinA for glabellar lines.
Doris Hexsel, Cristiano Brum, Carolina Siega, Juliana Schilling-Souza, Taciana Dal'Forno, Marc Heckmann

Dermatol Surg· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin overrides depression: not surprising, yet sensational.
Marc Heckmann, Andres Ceballos-Baumann

Dermatol Surg· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients.
Berthold Rzany, Dorothee Dill-Müller, Doris Grablowitz, Marc Heckmann, David Caird

Dermatol Surg· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making scents: improvement of olfactory profile after botulinum toxin-A treatment in healthy individuals.
Marc Heckmann, Sandra Kütt, Sabine Dittmar, Henning Hamm

Dermatol Surg· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
Marc Heckmann, Gerd Plewig,

Arch Dermatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet.
Nicholas J Lowe, Benjamin Ascher, Marc Heckmann, Catherine Kumar, Stephanie Fraczek

Dermatol Surg· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based medicine and the treatment of hyperhidrosis.
Marc Heckmann

J Am Acad Dermatol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Details from dignity to decay: facial expression lines in visual arts.
Marc Heckmann

Dermatol Surg· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear.
Marc Heckmann, Bianca Teichmann, Ulrike Schröder, Reiner Sprengelmeyer, Andrés O Ceballos-Baumann

J Am Acad Dermatol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperhidrosis of the axilla.
Marc Heckmann

Curr Probl Dermatol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A.
Marc Heckmann, Bianca Teichmann, Bettina M Pause, Gerd Plewig

Arch Dermatol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micrographic surgery of basal cell carcinomas of the head.
Birgit Woerle, Marc Heckmann, Birger Konz

Recent Results Cancer Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure.
Marc Heckmann, Frank Zogelmeier, Birger Konz

Arch Dermatol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study.
Marc Heckmann, Gisela Heyer, Birgit Brunner, Gerd Plewig

J Am Acad Dermatol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delusional hyperhidrosis as a risk for medical overtreatment: a case of botulinophilia.
Oliver P Kreyden, Marc Heckmann, Manfred Peschen

Arch Dermatol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis